Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014
Background: Autologous hematopoietic cell transplantation (THA) in patients with multiple myeloma and amyloidosis is the standard of care to promote disease free survival and quality of life. Aim: To report our experience with THA in patients with multiple myeloma. Material and Methods: Retrospectiv...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Lenguaje: | Spanish / Castilian |
| Publicado: |
Sociedad Médica de Santiago
2014
|
| Materias: | |
| Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014001200001 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:scielo:S0034-98872014001200001 |
|---|---|
| record_format |
dspace |
| spelling |
oai:scielo:S0034-988720140012000012015-02-19Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014Sarmiento,MauricioLira,PabloOcqueteau,MauricioRodríguez,María AlejandraGarcía,María JoséJara,VerónicaBertín,PabloRamírez,Pablo Amyloidosis Hematopoietic stem cell transplantation Multiple myeloma Background: Autologous hematopoietic cell transplantation (THA) in patients with multiple myeloma and amyloidosis is the standard of care to promote disease free survival and quality of life. Aim: To report our experience with THA in patients with multiple myeloma. Material and Methods: Retrospective review of the hematopoietic cell transplantation database of a hospital of a Medical School. Forty seven patients with multiple myeloma and six with amyloid light chain amyloidosis were identified. Clinical and demographic data were obtained from the records. Results: The overall five year survival of patients was 55%. Transplant-related or non-relapse mortality occurred in 7%. We found no differences in outcomes among patients younger or older than 50 years. Conclusions: Our data supports that THA can be done in our country with similar results to those obtained in international transplantation centers. Chronological age should not be a limitation to offer this therapy to patients with multiple myeloma and amyloidosis.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.142 n.12 20142014-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014001200001es10.4067/S0034-98872014001200001 |
| institution |
Scielo Chile |
| collection |
Scielo Chile |
| language |
Spanish / Castilian |
| topic |
Amyloidosis Hematopoietic stem cell transplantation Multiple myeloma |
| spellingShingle |
Amyloidosis Hematopoietic stem cell transplantation Multiple myeloma Sarmiento,Mauricio Lira,Pablo Ocqueteau,Mauricio Rodríguez,María Alejandra García,María José Jara,Verónica Bertín,Pablo Ramírez,Pablo Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| description |
Background: Autologous hematopoietic cell transplantation (THA) in patients with multiple myeloma and amyloidosis is the standard of care to promote disease free survival and quality of life. Aim: To report our experience with THA in patients with multiple myeloma. Material and Methods: Retrospective review of the hematopoietic cell transplantation database of a hospital of a Medical School. Forty seven patients with multiple myeloma and six with amyloid light chain amyloidosis were identified. Clinical and demographic data were obtained from the records. Results: The overall five year survival of patients was 55%. Transplant-related or non-relapse mortality occurred in 7%. We found no differences in outcomes among patients younger or older than 50 years. Conclusions: Our data supports that THA can be done in our country with similar results to those obtained in international transplantation centers. Chronological age should not be a limitation to offer this therapy to patients with multiple myeloma and amyloidosis. |
| author |
Sarmiento,Mauricio Lira,Pablo Ocqueteau,Mauricio Rodríguez,María Alejandra García,María José Jara,Verónica Bertín,Pablo Ramírez,Pablo |
| author_facet |
Sarmiento,Mauricio Lira,Pablo Ocqueteau,Mauricio Rodríguez,María Alejandra García,María José Jara,Verónica Bertín,Pablo Ramírez,Pablo |
| author_sort |
Sarmiento,Mauricio |
| title |
Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| title_short |
Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| title_full |
Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| title_fullStr |
Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| title_full_unstemmed |
Experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| title_sort |
experiencia de 22 años de trasplante autólogo de células hematopoyéticas en pacientes con mieloma múltiple o amiloidosis sistémica. 1992-2014 |
| publisher |
Sociedad Médica de Santiago |
| publishDate |
2014 |
| url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014001200001 |
| work_keys_str_mv |
AT sarmientomauricio experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT lirapablo experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT ocqueteaumauricio experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT rodriguezmariaalejandra experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT garciamariajose experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT jaraveronica experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT bertinpablo experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 AT ramirezpablo experienciade22anosdetrasplanteautologodecelulashematopoyeticasenpacientesconmielomamultipleoamiloidosissistemica19922014 |
| _version_ |
1718436791153852416 |